drugset / Trial / NCT00895726

Pilot Study of APD209 in Cancer Cachexia

NCT00895726 ↗

Phase 2 Completed 13 enrolled Acacia Pharma Ltd
NaSingle-groupOpen-labelTreatment

Summary

Primary Objective: To assess the efficacy of APD209 in adult patients with active cachexia associated with advanced malignancy and not caused by simple starvation. Secondary Objective: To assess the safety of APD209 in patients with advanced malignancy and active cachexia.

Timeline

Start
2009-03
Primary completion
2011-11
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject APD209 Unknown — Oral

Indications

No indication recorded.